Phytosphingosines constitute a group of functionally related, long-chain aliphatic 2-amino-1,3,4-triols of which D-ribo-C18-phytosphingosine ((2S,3S,4R)-2-aminooctadecane-1,3,4-triol) is the most prevalent. D-ribo-Phytosphingosine is a bioactive lipid and is reported to be a potential heat stress signal in yeast cells. Phytosphingosines are widely distributed as structural components of sphingolipids in yeast, fungi, mammalian tissues and marine organisms. The long-chain base (phytosphingosine component) of the majority of the phytosphingolipids has 18-carbons minor amounts of other chain lengths, especially C20, are also found, depending on their origin. Some of these phytosphingolipids exhibit important physiological activities. For example, there are α-and β-galactosyl- and glucosylphytoceramides that possess high tumor inhibitory potency. Due to the variety and significance of their biological activities and their scarcity in nature, phytosphingosines have become important synthetic targe ts. In general, approaches can be placed into three main categories. The first two rely on the chiral pool of amino acids and carbohydrates as the foundation for the asymmetric centers. Most amino acid strategies utilize (L)-serine. The carbohydrate-based approaches are the most abundant and employ a variety of common sugars and amino sugars. The third category of syntheses is based on asymmetric transformations. In this review the biological importance of phytosphingosines will be highlighted and approaches to their synthesis will be reviewed.
β-Sitosterol (β-Sit) is a dietary phytosterol with demonstrated anticancer activity against a panel of cancers, but its poor solubility in water limits its bioavailability and therapeutic efficacy. In this study, poly(lactide-co-glycolic acid) (PLGA) and block copolymers of poly(ethylene glycol)-block-poly(lactic acid) (PEG-PLA) were used to encapsulate β-Sit into nanoparticles with the aim of enhancing its in vitro anticancer activity. β-Sitosterol-loaded PLGA and PEG-PLA nanoparticles (β-Sit-PLGA and β-Sit-PEG-PLA) were prepared by using a simple emulsion-solvent evaporation technique. The nanoparticles were characterized for size, particle size distribution, surface charge, and encapsulation efficiency. Their cellular uptake and antiproliferative activity was evaluated against MCF-7 and MDA-MB-231 human breast cancer cells using flow cytometry and MTT assays, respectively. β-Sit-PLGA and β-Sit-PEG-PLA nanoparticles were spherical in shape with average particle sizes of 215.0 ± 29.7 and 240.6 ± 23.3 nm, a zeta potential of −13.8 ± 1.61 and −23.5 ± 0.27 mV, respectively, and with narrow size distribution. The encapsulation efficiency of β-Sit was 62.89 ± 4.66 and 51.83 ± 19.72 % in PLGA and PEG-PLA nanoparticles, respectively. In vitro release in phosphate-buffered saline (PBS) and PBS/with 0.2% Tween 20 showed an initial burst release, followed by a sustained release for 408 h. β-Sit-PLGA nanoparticles were generally stable in a protein-rich medium, whereas β-Sit-PEG-PLA nanoparticles showed a tendency to aggregate. Flow cytometry analysis (FACS) indicated that β-Sit-PLGA nanoparticles were efficiently taken up by the cells in contrast to β-Sit-PEG-PLA nanoparticles. β-Sit-PLGA nanoparticles were therefore selected to evaluate antiproliferative activity. Cell viability was inhibited by up to 80% in a concentration range of 6.64–53.08 μg/mL compared to the untreated cells. Taken together, encapsulation of β-Sitosterol in PLGA nanoparticles is a promising strategy to enhance its anticancer activity against breast cancer cells.
21 August 1999 in The Journal of Organic Chemistry